ImmunoACT shared on Twitter:
“A New Hope: India’s First Approved CAR-T Cell Therapy – No Longer Sci-Fi, Now a Reality!
We are pleased to announce the receipt of a Marketing Authorization Approval from the CDSCO for NexCAR19. Check the link to find out the latest press release.”
Source: ImmunoACT/Twitter